# Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic

> **NCT04517097** · — · COMPLETED · sponsor: **Centre Georges Francois Leclerc** · enrollment: 1680 (actual)

## Conditions studied

- Cancer

## Interventions

- **BIOLOGICAL:** blood sample

## Key facts

- **NCT ID:** NCT04517097
- **Lead sponsor:** Centre Georges Francois Leclerc
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-12
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 1680 (ACTUAL)
- **Last updated:** 2020-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04517097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04517097, "Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04517097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*